Genesis HealthCare (GEN) Misses Q4 EPS by 1c ; Offers Guidance

Genesis HealthCare (NASDAQ: GEN) reported Q4 EPS of $0.49, $0.01 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $951 million versus the consensus estimate of $955.96 million.

GUIDANCE:

Genesis HealthCare sees Q1 2024 EPS of $0.52-$0.54, versus the consensus of $0.53. Genesis HealthCare sees Q1 2024 revenue of $960-970 million, versus the consensus of $974.4 million.

Genesis HealthCare sees FY2024 EPS of $1.95-$1.97, versus the consensus of $1.97. Genesis HealthCare sees FY2024 revenue of $3.81-3.82 billion, versus the consensus of $3.82 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Middleby board approves spin-off of food processing unit Midera